NO20071319L - Fremgangsmate for fremstilling av isotiazolderivater. - Google Patents
Fremgangsmate for fremstilling av isotiazolderivater.Info
- Publication number
- NO20071319L NO20071319L NO20071319A NO20071319A NO20071319L NO 20071319 L NO20071319 L NO 20071319L NO 20071319 A NO20071319 A NO 20071319A NO 20071319 A NO20071319 A NO 20071319A NO 20071319 L NO20071319 L NO 20071319L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- isothiazole derivatives
- isothiazole
- derivatives
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Fremgangsmåter og intermediater for fremstilling av forbindelser med formel (I) og farmasøytiske akseptable salter, prodrugs, solvater og hydrater derav, hvori R1, R2 og R3 har definisjonene tilveiebragt heri.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60454204P | 2004-08-26 | 2004-08-26 | |
PCT/US2005/027398 WO2006026034A2 (en) | 2004-08-26 | 2005-08-02 | Processes for the preparation of isothiazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071319L true NO20071319L (no) | 2007-05-29 |
Family
ID=36000502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071319A NO20071319L (no) | 2004-08-26 | 2007-03-09 | Fremgangsmate for fremstilling av isotiazolderivater. |
Country Status (22)
Country | Link |
---|---|
US (2) | US8884025B2 (no) |
EP (1) | EP1784183B1 (no) |
JP (2) | JP5100390B2 (no) |
KR (1) | KR100893977B1 (no) |
CN (1) | CN101043888B (no) |
AR (1) | AR050613A1 (no) |
AT (1) | ATE542533T1 (no) |
AU (1) | AU2005280451B2 (no) |
BR (1) | BRPI0514667A (no) |
CA (1) | CA2578023C (no) |
DK (1) | DK1784183T3 (no) |
ES (1) | ES2378994T3 (no) |
HK (1) | HK1111359A1 (no) |
IL (1) | IL181063A0 (no) |
MX (1) | MX2007002246A (no) |
NO (1) | NO20071319L (no) |
PL (1) | PL1784183T3 (no) |
PT (1) | PT1784183E (no) |
RU (1) | RU2349588C2 (no) |
TW (1) | TWI361688B (no) |
WO (1) | WO2006026034A2 (no) |
ZA (1) | ZA200701016B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8884025B2 (en) | 2004-08-26 | 2014-11-11 | David B. Damon | Processes for the preparation of isothiazole derivatives |
ES2851602T3 (es) | 2011-12-28 | 2021-09-08 | Allergan Inc | Derivados de 3-fenil-5-ureidoisotiazol-4-carboxamida como inhibidores de cinasa |
CN103833665B (zh) * | 2014-02-24 | 2015-09-23 | 杰达维(上海)医药科技发展有限公司 | 一种新的合成异噻唑的方法 |
US9353093B2 (en) | 2014-10-07 | 2016-05-31 | Allergan, Inc. | Indole-1-carboxamides as kinase inhibitors |
US9403803B2 (en) | 2014-10-08 | 2016-08-02 | Allergan, Inc. | Indole-3-carboxamides as kinase inhibitors |
US9359336B2 (en) | 2014-10-09 | 2016-06-07 | Allergan, Inc. | Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors |
US9371314B2 (en) | 2014-10-09 | 2016-06-21 | Allergan, Inc. | Pyridyl benzothiophenes as kinase inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2408234A1 (de) * | 1974-02-21 | 1975-09-04 | Celamerck Gmbh & Co Kg | Isothiazolylharnstoffe |
US4059433A (en) * | 1976-06-18 | 1977-11-22 | Fmc Corporation | 3-Alkoxyisothiazole derivatives as herbicides |
IL72093A0 (en) * | 1983-06-20 | 1984-10-31 | Lilly Co Eli | N'-substituted(3-alkyl-5-isothiazolyl)urea derivatives |
UA60365C2 (uk) | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
JP4511352B2 (ja) * | 2002-07-25 | 2010-07-28 | ファイザー・インク | 抗癌薬として有用なイソチアゾール誘導体 |
US20060035954A1 (en) * | 2004-08-11 | 2006-02-16 | Sharma Padam N | Ammonolysis process for the preparation of intermediates for DPP IV inhibitors |
US8884025B2 (en) | 2004-08-26 | 2014-11-11 | David B. Damon | Processes for the preparation of isothiazole derivatives |
-
2005
- 2005-08-02 US US11/574,046 patent/US8884025B2/en not_active Expired - Fee Related
- 2005-08-02 PT PT05778840T patent/PT1784183E/pt unknown
- 2005-08-02 PL PL05778840T patent/PL1784183T3/pl unknown
- 2005-08-02 KR KR1020077004371A patent/KR100893977B1/ko active IP Right Grant
- 2005-08-02 DK DK05778840.8T patent/DK1784183T3/da active
- 2005-08-02 JP JP2007537876A patent/JP5100390B2/ja not_active Expired - Fee Related
- 2005-08-02 WO PCT/US2005/027398 patent/WO2006026034A2/en active Application Filing
- 2005-08-02 CN CN2005800284337A patent/CN101043888B/zh not_active Expired - Fee Related
- 2005-08-02 MX MX2007002246A patent/MX2007002246A/es active IP Right Grant
- 2005-08-02 ES ES05778840T patent/ES2378994T3/es active Active
- 2005-08-02 AT AT05778840T patent/ATE542533T1/de active
- 2005-08-02 AU AU2005280451A patent/AU2005280451B2/en not_active Ceased
- 2005-08-02 RU RU2007106847/04A patent/RU2349588C2/ru not_active IP Right Cessation
- 2005-08-02 BR BRPI0514667-4A patent/BRPI0514667A/pt active Search and Examination
- 2005-08-02 EP EP05778840A patent/EP1784183B1/en not_active Not-in-force
- 2005-08-02 CA CA2578023A patent/CA2578023C/en not_active Expired - Fee Related
- 2005-08-22 TW TW094128618A patent/TWI361688B/zh not_active IP Right Cessation
- 2005-08-23 AR ARP050103539A patent/AR050613A1/es not_active Application Discontinuation
-
2007
- 2007-01-30 IL IL181063A patent/IL181063A0/en unknown
- 2007-02-02 ZA ZA200701016A patent/ZA200701016B/xx unknown
- 2007-03-09 NO NO20071319A patent/NO20071319L/no not_active Application Discontinuation
-
2008
- 2008-02-25 HK HK08102078.3A patent/HK1111359A1/xx not_active IP Right Cessation
-
2012
- 2012-03-30 JP JP2012079463A patent/JP5498524B2/ja not_active Expired - Fee Related
-
2014
- 2014-11-10 US US14/537,093 patent/US9371298B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200708159B (en) | 1-Acetic acid-indole derivatives with PDG2 antagonist activity | |
HK1119699A1 (en) | Pyridopyrimidinone inhibitors of pi3kalpha | |
NO20076066L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
NO20051303L (no) | Nye benzoimidazolderivater nyttige som antiproliferative midler | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
NO20071319L (no) | Fremgangsmate for fremstilling av isotiazolderivater. | |
ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
TW200833675A (en) | Nicotinamide derivatives | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
MX2009004900A (es) | Arilamidas sustituidas por tiazol u oxazol. | |
WO2006113509A3 (en) | Quinobenzoxazine analogs and methods of using thereof | |
MX2007007105A (es) | Procedimiento para la preparacion de un derivado de 2-piridiletilcarboxamida. | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
NO20082112L (no) | 3-Amino-2-arylpropylazaindoler og deres anvendelse | |
TW200500339A (en) | Pyrrolidine derivatives, and process for the preparation | |
NO20065873L (no) | 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
NO20075409L (no) | Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater | |
NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
NO20076000L (no) | Aminosyrederivater | |
SI1845780T1 (sl) | Uporaba derivatov metilfenidata | |
TW200635592A (en) | Pyridyl-substituted spiro-hydantoin compounds and use thereof | |
IL186832A0 (en) | Process for the preparation of a carboxamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |